Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Non-Current Assets (2018 - 2025)

Neurogene's Non-Current Assets history spans 6 years, with the latest figure at $16.8 million for Q4 2025.

  • For Q4 2025, Non-Current Assets fell 15.01% year-over-year to $16.8 million; the TTM value through Dec 2025 reached $71.4 million, down 13.12%, while the annual FY2025 figure was $16.8 million, 15.01% down from the prior year.
  • Non-Current Assets reached $16.8 million in Q4 2025 per NGNE's latest filing, down from $17.3 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $22.2 million in Q4 2023 to a low of $9.7 million in Q3 2023.
  • Average Non-Current Assets over 3 years is $17.4 million, with a median of $18.6 million recorded in 2025.
  • Peak YoY movement for Non-Current Assets: surged 111.21% in 2024, then dropped 15.43% in 2025.
  • A 3-year view of Non-Current Assets shows it stood at $22.2 million in 2023, then decreased by 10.88% to $19.8 million in 2024, then dropped by 15.01% to $16.8 million in 2025.
  • Per Business Quant, the three most recent readings for NGNE's Non-Current Assets are $16.8 million (Q4 2025), $17.3 million (Q3 2025), and $18.3 million (Q2 2025).